Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2017-08-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establish Implant Accuracy With X-PSI Knee System
NCT03275246
Evaluate E1 Wear, Clinical Performance of E1 Liner in THA in Korean Patient Population
NCT02087449
Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty
NCT02962362
Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components
NCT02668211
All Polyethylene Tibia-VEGA Kiel
NCT02756702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Indication for primary THA with cementless Excia T® stem
Exclusion Criteria
* THA after fracture
* Rheumatoid arthritis
* Systemic disorders, treated with Cortisone or other pharmaceuticals, potentially compromising the bone quality
* Patient physically or mentally not able to follow the postoperative examination routine
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. med. E. Mayr
Celle, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1612
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.